Vascular endothelial growth factor in reproductive biology

Current Opinion in Obstetrics and Gynecology

Volumn 11, Issue 3, 1999, Pages 255-260

  Lebovic, Dan I ^a   Mueller, Michael D ^a   Taylor, Robert N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CYTOLOGY; ENDOMETRIOSIS; FEMALE; HORMONAL REGULATION; HORMONE ACTION; HUMAN; HYPOPHYSIS; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; PREGNANCY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ENDOMETRIUM; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; LYMPHOKINES; OVARY; PITUITARY GLAND; PREGNANCY; REPRODUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032828783     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001703-199906000-00004     Document Type: Article

References (54)

1. Augustin HG. Antiangiogenic tumour therapy: Will it work? Trends Pharmacol Sci 1998; 19:216-222.
2. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86:353-364.
3. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, Abraham JA. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 1991; 266:11947-11954.
4. Houck K, Ferrara N, Winer J, Cachianes G, Li B, Leung D. The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 1991; 5:1806-1814.
5. Charnock-Jones D, Sharkey A, Rajput-Williams J, Burch D, Shofield J, Fountain S et al. Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines. Biol Reprod 1993; 48:1120-1128.
6. Dlugi AM. Hyperprolactinemic recurrent spontaneous pregnancy loss: A true clinical entity or spurious finding? Fertil Steril 1988; 70:253-255.
7. Elias KA, Weiner RI. Direct arterial vascularization of estrogen-induced prolactin-secreting anterior pituitary tumors. Proc Natl Acad Sci USA 1984; 81:4549-4553.
8. Banerjee SK, Sarkar DK, Weston AP, De A, Campbell DR. Overexpression of vascular endothelial growth factor and its receptor during the development of estrogen-induced rat pituitary tumors may mediate estrogen-initiated tumor angiogenesis. Carcinogenesis 1997; 18:1155-1161.
9. Jabbour HN. Pattern and localisation of expression of vascular endothelial growth factor and its receptor fit-1 in the ovine pituitary gland: Expression is independent of hypothalamic control. Mol Cell Endocrinol 1997; 134:91-100.
10. Schechter J, Goldsmith P, Wilson C, Weiner R. Morphological evidence for the presence of arteries in human prolactinomas. J Clin Endocrinol Metab 1988; 67:713-719.
11. Suzuki T, Sasano H, Takaya R, Fukaya T, Yajima A, Nagura H. Cyclic changes of vasculature and vascular phenotpyes in normal human ovaries. Hum Reprod 1998; 13:953-959.
12. Lee A, Christenson LK, Patton PE, Burry KA, Stouffler RL. Vascular endothelial growth factor production by human luteinized granulosa cells in vitro. Hum Reprod 1997; 12:2756-2761.
13. Anasti J, Kalantaridou S, Kimzey L, George M, Nelson L. Human follicle fluid vascular endothelial growth factor concentrations are correlated with luteinization in spontaneously developing follicles. Hum Reprod 1998; 13:1144-1147.
14. Laitinen M, Ristimaki A, Honkasalo M, Narko K, Paavonen K, Ritvos O. Differential hormonal regulation of vascular endothelial growth factors VEGF, VEGF-B, and VEGF-C messenger ribonucleic acid levels in cultured human granuloa-luteal cells. Endocrinology 1997; 138:4748-4756.
15. Goede V, Schmidt T, Kimmina S, Kozian D, Augustin H. Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis. Lab Invest 1990; 78:1385-1394.
16. Ferrara N, Chen H, Davis-Smyth T, Gerber H, Nguyen T, Peers D, et al. Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nature Med 1998; 4:336-340. This study elegantly argues in favor of a dominant role for VEGF in the corpus luteum by observing that corpus luteum angiogenesis was suppressed when rats were treated with a truncated soluble VEGF receptor.
17. Antczak M, Blerkom JV, Clark A. A novel mechanism of vascular endothelial growth factor, leptin and transforming growth factor-β2 sequestration in a subpopulation of human ovarian follicle cells. Hum Reprod 1997; 12:2226-2234.
18. Doldi N, Bassan M, Fusi FM, Ferrari A. In controlled ovarian hyperstimulation, steroid production, oocyte retrieval, and pregnancy rate correlate with gene expression of vascular endothelial growth factor. J Assist Reprod Genet 1997; 14:589-592.
19. Friedman CI, Seifer DB, Kennard EA, Arbogast L, Alak B, Danforth DR. Elevated level of follicular fluid vascular endothelial growth factor is a marker of diminished pregnancy potential. Fertil Steril 1998; 70:836-839.
20. Lee A, Christenson K, Stouffer RL, Burry KA, Patton PE. Vascular endothelial growth factor levels in serum and follicular fluid of patients undergoing in vitro fertilization. Fertil Steril 1997; 68:305-311.
21. Kamat BR, Brown LF, Manseau EJ, Senger DR, Dvorak HF. Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Role in corpus luteum development. Am J Pathol 1995; 146:157-165.
22. Agrawall R, Sladkevicius P, Engmann L, Conway GS, Payne NN, Bekis J, et al. Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with potycystic ovaries. Hum Reprod 1998; 13:651-655. A total of 60 women (14 with PCOS) were studied during an IVF stimulation cycle. Significantly greater serum concentrations of VEGF and higher stromal blood flow velocities were found in the PCOS group.
23. Agrawal R, Conway G, Sladkevicius P, Tan SL, Engmann L, Payne N, et al. Serum vascular endothelial growth factor and Doppler blood flow velocities in an in vitro fertilization: Relevance to ovarian hyperstimulation syndrome and polycystic ovaries. Fertil Steril 1998; 70:651-658.
24. Abramov Y, Barak V, Nisman B, Schenker JG. Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome. Fertil Steril 1997; 67:261-265.
25. Artini PG, Fasciani A, Monti M, Luisi S, D'Ambrogio G, Genazzani AR. Changes in vascular endothelial growth factor levels and the risk of ovarian hyperstimulatlon syndrome in women enrolled in an in vitro fertilization program. Fertil Steril 1998; 70:560-564.
26. Levin E, Rosen G, Cassidenti D, Yee B, Meldrum D, Wisot A, Pedram A. Role of vascular endothelial cell growth factor in ovarian hyperstimulation syndrome. J Clin Invest 1998; 102:1978-1985. Follicular fluid from 60 women undergoing IVF stimulation could induce endothelial cell permeability in vitro. The primary role of VEGF was demonstrated by reversing the permeability with VEGF antibodies.
27. Ludwig M, Gembruch U, Bauer O, Diedrich K. Ovarian hyperstimulation syndrome (OHSS) in a spontaneous pregnancy with fetal and placental triploidy; information about the general pathophysiology of OHSS. Hum Reprod 1998; 13:2082-2087.
28. Koboyashi H, Okada Y, Asahina T, Gotoh J, Terao T. The kallikrein-kinin system, but not vascular endothelial growth factor, plays a role in the increased vascular permeability associated with ovarian hyperstimulation syndrome. J Mol Endocrinol 1998; 20:363-374.
29. Ludwig M, Bauer O, Lopens A, Jelkmann W, Diedrich K. Serum concentration of vascular endothelial growth factor cannot predict the course of severe ovarian hyperstimulation syndrome. Hum Reprod 1998; 13:30-32.
30. Shifren J, Tseng J, Zaloudek C, Ryan IP, Meng YG, Ferrara N, et al. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: Implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J Clin Endocrinol Metab 1996; 81:3112-3118.
31. Cullinan-Bove K, Koos R. Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: Rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth. Endocrinology 1993; 133:829-837.
32. Greb R, Heikinheimo O, Williams R, Hodgen G, Goodman A. Vascular endothelial growth factor in primate endometrium is regulated by oeetregen-receptor and progasterone-receptor ligands in vivo. Hum Reprod 1997; 12:1280-1292.
33. Karuri A, Kumar A, Mukhopadhyay D. Differential expression and selective localization of vascular permeability factor/vascular endothelial growth factor in the rat uterus during the estrous cycle. J Endocrinol 1998; 159:488-499.
34. Zhang L, Scoff P, Turley H, Leek R, Lewis C, Gatter K, et al. Validation of anti-vascular endothelial growth factor (anti-VEGF}) antibodies for immunohistochemical localization of VEGF in tissue sections: Expression of VEGF in the human endometrium. J Pathol 1998; 185:402-408.
35. Homung D, Lebovic D, Shifren J, Vigne J, Taylor R. Vectorial secretion of vascular endothelial growth factor by polarized human endometrial epithelial cells. Fertil Steril 1998; 69:909-915.
36. Hyder S, Chiapetta C, Stancel G. Triphenylethylene antioestrogens induce uterine vascular endothelial growth factor expression via their partial estrogen agonist activity. Cancer Letters 1997; 120:165-171.
37. Nisolle M, Casanas Roux B, Anaf V, Mine J, Donnez J. Morphometric study of the stromal vascularization in peritoneal endometriosis. Fertil Steril 1993; 59:681-684.
38. Donnez J, Smoes P, Gillerot S, Casanas-Roux F, Nisolle M. Vascular endothelial growth factor (VEGF) in endometriosis. Hum Reprod 1998; 13:1686-1690. The authors demonstrate a correlation between the VEGF content of different endometriotic lesions suggesting that after exfoliation and attachment of endometrial cells, high levels of VEGF provoke vascularization and facilitate viability of the red lesions. Lower levels of VEGF in black lesions explain the decrease in stromal vascularization, followed by fibrosis and inactivation of the implant.
39. Nisolle M, Donnez J. Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entitites. Fertil Steril 1997; 68:585-596.
40. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996; 380:439-442.
41. Fong GH, Rossant J, Gedsenstein M, Breitman ML. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 1995; 376:66-70.
42. Athanassiades A, Hamilton GS, Lala PK. Vascular endothelial growth factor stimulates proliferation but not migration or invasiveness in human extravillous trophoblast. Biol Reprod 1998; 59:643-654.
43. Clark DE, Smith SK, Sharkey AM, Charnock-Jones DS. Localization of VEGF and expression of its receptors flt and KDR in human placenta throughout pregnancy. Hum Reprod 1996; 11:1090-1098.
44. Simon M, Rockl W, Homig C, Grone EF, Theis H, Weich HA, et al. Receptors of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in fetal and adult human kidney: Localization and [1251]VEGF binding sites. J Am Soc Nephrol 1998; 9:1032-1044.
45. Kitamoto Y, Tokunaga H, Tomita K. Vascular endothelial growth factor is an essential molecule for mouse kidney development: Glomerulogenesis and nephrogenesis. J Clin Invest 1997; 99:2351-2357.
46. Ni Y, May V, Brass K, Osol G. Pregnancy augments uteroplacental vascular endothelial growth factor gene expression and vasodilator effects. Am J Physiol 1997; 273:H938-H944.
47. Cooper JC, Sharkey AM, Chamock-Jones DS, Palmer CR, Smith SK. VEGF mRNA levels in placentae from pregnancies complicated by pre-eclampsia. Br J Obstet Gynaecol 1996; 103:1191-1196.
48. Evans PW, Wheeler T, Anthony FW, Osmond C. A longitudinal study of maternal serum vascular endothelial growth factor in early pregnancy. Hum Reprod 1998; 13:1057-1062.
49. Baker PN, Krasnow J, Roberts JM, Yeo KT. Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia. Obstet Gynecol 1995; 86:815-821.
50. Sharkey AM, Cooper JC, Balmforth JR, McLaren J, Clark DE, Chamock-Jones DS, et al. Maternal plasma levels of vascular endothelial growth factor in normotaneive normotensive pregnancies and in pregnancies complicated by pre-eclampsia. Eur J Clin Invest 1996; 26:1182-1185.
51. Lyall F, Young A, Boswell F, Kingdom JC, Greer IA. Placental expression of vascular endothelial growth factor in placentae from pregnancies complicated by pre-eclampsia and intrauterine growth restriction does not support placental hypoxia at delivery. Placenta 1997; 18:269-276.
52. Koblizek TI, Weiss C, Yancopoulos GD, Deutsch U, Risau W. Angiopoietin-1 induces sprouting angiogenesis in vitro. Current Biology 1998; 8:529-532.
53. Mesiano S, Ferrara N, Jaffe R. Role of vascular endothelial growth factor in ovarian cancer: Inhibition of ascites formation by immunoneutralization. Am J Pathol 1998; 153:1249-1256.
54. Taylor RN, Ryan IP, Moore ES, Hornung D, Shifren JL, Tseng JF. Angiogenesis and macrophage activation in endometriosis. Ann NY Acad Sci 1997; 828:194-207.